The purpose of the HEALEY ALS Platform Trial is to evaluate the safety and effectiveness of multiple treatments for amyotrophic lateral sclerosis (ALS). A regimen is a specific course of treatment, each with a different study drug. Multiple regimens may be active at the same time within this platform trial. Participants will be randomly assigned to a regimen (one treatment). Within a regimen, participants will have a 3 in 4 chance of being assigned to the active drug group and a 1 in 4 chance of being assigned to the placebo (inactive substance) group. Researchers aim to determine whether these treatments have an effect on ALS and can be safely used without causing excessive side effects.
The HEALEY ALS Platform Trial
What is the full name of this clinical trial?
The Healey ALS Platform Trial